Trial: 202003057

Phase II/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)

Phase

II/III

Principal Investigator

Pedersen, Katrina

Disease Site

Colon

Learn more about this study at: clinicaltrials.gov